Economic Opportunity: Brand Drugs vs. Generic Drugs
Abstract
Outlines:
* Pharmaceutical markets in the Middle East region are attractive
*The high spending on branded drugs is unsustainable
*Publicly funded health systems – increased pressure to reduce rising drug budgets
*Originator (NDA) vs Generic (ANDA) review process requirements 20-90% cheaper generics
* The generic drug industry is responsible for making more affordable and cost-saving medicines
DOI/handle
http://hdl.handle.net/10576/6704Collections
- Forums & Dialogues [57 items ]
- Medication sector in Qatar: Hand in Hand Facing the blockade (9 – 10 March 2018) [13 items ]
- Pharmacy Research [1291 items ]